TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT06256575: Treatment of Digital Ulcers in Systemic Sclerosis With Diosmin: A Randomized, Double-blind, Placebo-controlled Multi-centre Pilot Study

Sponsor: Primus Pharmaceuticals · Phase: PHASE2 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 45 pts

Competing Trials Overlap

2 Active Trials

Excess Burn Exposure

$6,507,200

Rescue Site Savings

+$4,282,800

Unlock Full NCT06256575 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT06256575 Rescue Dossier →